Fabio \u00d6ster,<\/strong> co-founder of AixSwiss says: \u201cI am very happy we have been able to find an entrepreneurial group like Vision Healthcare to join forces with. In our discussions with Vision\u2019s teams, J\u00f6rg and I believe that we have found the perfect partner to further develop the business and grow together with Vision itself. The entire AixSwiss team is looking forward to working together. The Clairfield team was a 100% reliable and professional partner throughout the whole process and helped us outperform our goals.\u201d<\/em><\/p>\n\n\n\n Geert Cools<\/strong>, CEO of Vision Healthcare, says: \u201cWe are very pleased to welcome Nupure in the Vision Healthcare family of brands. Nupure is an impressive growth story of a digital native probiotic nutraceutical brand establishing a market leading presence in the DACH e-channels after a couple of years\u2019 time. The integration of Nupure will further reinforce Vision Healthcare\u2019s position as a leading digital omnichannel in the VMS & Nutraceuticals market and will strengthen Vision Healthcare\u2019s portfolio in high growth spaces to serve the growing nutraceutical consumer needs.\u201d<\/em><\/p>\n\n\n\n Yvan Vindevogel<\/strong>, Chairman of the executive committee of Vision Healthcare says: \u201cAfter a very intensive M&A year in 2021, we\u2019ve spent 2022 in further developing and integrating our Group while looking out for interesting and strategic M&A targets. Nupure fits in our ambitious expansion strategy as the leading consolidator in the still deeply fragmented European D2C healthcare space. With the Nupure brand acquisition, Vision Healthcare is further establishing itself as the leading pan-European digital omnichannel online consumer healthcare platform.\u201d<\/em><\/p>\n\n\n\n Albert Schander<\/strong>, co-founder and board member of Clairfield, says: \u201cThe successful sale of AixSwiss is another landmark transaction that showcases Clairfield\u2019s expertise in hot-spot industries such as e-commerce, consumer health, and food supplements.<\/em> We wish J\u00f6rg and Fabio the best of success for their upcoming journey with Vision Healthcare.\u201d<\/em><\/p>\n\n\n\n Konstantin Zygan<\/strong>, director at Clairfield in charge of process management, says: \u201cOur team was able to execute an extremely efficient and streamlined M&A process, accessing all relevant European offline and online pharma players to position the USPs of AixSwiss convincingly. We are proud of the transaction outcome in every aspect.\u201d<\/em><\/p>\n\n\n\n Dentons Frankfurt and Amsterdam <\/strong><\/strong>(Dr. Volker Junghanns, Kuif Klein Wassink) provided legal transaction advice to the Sellers.<\/p>\n\n\n\n
![\"\"](\"https:\/\/www.clairfield.com\/wp-content\/uploads\/2022\/09\/aixswiss.png\")
<\/figure>\n<\/div>\n\n\n\n![\"\"](\"https:\/\/www.clairfield.com\/wp-content\/uploads\/2022\/09\/Vision-Healthcare.png\")
<\/figure>\n<\/div>\n\n\n\n